#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Lars Veen Email
COO . iOnctura
,
LocationPrimary Email
How to contact Lars Veen
Join and see Lars's contact info for free!Current Roles
Employees:
32Revenue:
$5MAbout
iOnctura, headquartered in Geneva, Switzerland, was founded in June 2017 as a spin out from Merck KGaA, funded by Merck Ventures. It is a late stage preclinical biotechnology company developing a pipeline of next generation, best-in-class molecules for the treatment of cancer and fibrosis. With its programs harnessing both immune-mediated and direct anti-tumour activity iOnctura aims to deliver superior clinical efficacy in oncology. By building on complimentary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet medical need in fibrotic diseases. iOnctura strives to develop differentiated and targeted development strategies based on the latest scientific insights. Through its strong collaborations with Cancer Research UK and the NKI (the Dutch Cancer Institute), iOnctura has access to world renowned experts in the field to support and advance its programs.iOnctura Address
Campus Biotech Innovation Park, Bâtiment F2,null, null